RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
80 hedge funds and large institutions have $379M invested in Repros Therapeutics Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $12.7M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
80
Holding in Top 10
1
Calls
$10.6M
Puts
$12.7M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$22M | |
| 3 | +$14.5M | |
| 4 |
DCM
Destrier Capital Management
New York
|
+$3.57M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.28M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$21.9M | |
| 3 | -$10.7M | |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$7.71M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.55M |